Atul Vashist
Atul Vashist
Senior Scientist, BSL-3 Facility, Centralized Core Research Facility, AIIMS, New Delhi, India.
Verified email at
Cited by
Cited by
Recent advances in hydrogel based drug delivery systems for the human body
A Vashist, A Vashist, YK Gupta, S Ahmad
Journal of Materials Chemistry B 2 (2), 147-166, 2014
Advances in carbon nanotubes–hydrogel hybrids in nanomedicine for therapeutics
A Vashist, A Kaushik, A Vashist, V Sagar, A Ghosal, YK Gupta, S Ahmad, ...
Advanced healthcare materials 7 (9), 1701213, 2018
Appropriate DevR (DosR)-mediated signaling determines transcriptional response, hypoxic viability and virulence of Mycobacterium tuberculosis
S De Majumdar, A Vashist, S Dhingra, R Gupta, A Singh, VK Challu, ...
PLoS One 7 (4), e35847, 2012
Recent trends on hydrogel based drug delivery systems for infectious diseases
A Vashist, A Kaushik, A Vashist, RD Jayant, A Tomitaka, S Ahmad, ...
Biomaterials science 4 (11), 1535-1553, 2016
Nanogels as potential drug nanocarriers for CNS drug delivery
A Vashist, A Kaushik, A Vashist, J Bala, R Nikkhah-Moshaie, V Sagar, ...
Drug discovery today 23 (7), 1436-1443, 2018
Essentiality of DevR/DosR interaction with SigA for the dormancy survival program in Mycobacterium tuberculosis
US Gautam, K Sikri, A Vashist, V Singh, JS Tyagi
Journal of bacteriology 196 (4), 790-799, 2014
An approach for conjugation of 177Lu-DOTA-SCN-Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients
P Thakral, S Singla, MP Yadav, A Vasisht, A Sharma, SK Gupta, CS Bal
The Indian journal of medical research 139 (4), 544, 2014
Nanogels for biomedical applications
A Vashist, AK Kaushik, S Ahmad, M Nair
Royal Society of Chemistry, 2017
Co-expression of devR and DevRN-Aph proteins is associated with hypoxic adaptation defect and virulence attenuation of Mycobacterium tuberculosis
S De Majumdar, D Sharma, A Vashist, K Kaur, NK Taneja, S Chauhan, ...
PLoS One 5 (2), e9448, 2010
Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs
K Sikri, P Duggal, C Kumar, SD Batra, A Vashist, A Bhaskar, K Tripathi, ...
Redox biology 15, 452-466, 2018
Bioresponsive injectable hydrogels for on-demand drug release and tissue engineering
A Vashist, A Kaushik, K Alexis, R Dev Jayant, V Sagar, A Vashist, M Nair
Current pharmaceutical design 23 (24), 3595-3602, 2017
The α10 helix of DevR, the Mycobacterium tuberculosis dormancy response regulator, regulates its DNA binding and activity
A Vashist, D Prithvi Raj, UD Gupta, R Bhat, JS Tyagi
The FEBS journal 283 (7), 1286-1299, 2016
Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent Mycobacterium tuberculosis
A Vashist, V Malhotra, G Sharma, JS Tyagi, JE Clark-Curtiss
Journal of Biological Chemistry 293 (42), 16413-16425, 2018
Journey of hydrogels to nanogels: a decade after
A Vashist, A Kaushik, A Ghosal, R Nikkhah-Moshaie, A Vashist, ...
Royal Society of Chemistry, 2017
Hydrogels: stimuli responsive to on-demand drug delivery systems
A Vashist, A Kaushik, RD Jayant, A Vashist, A Ghosal, M Nair
Advances in personalized nanotherapeutics, 117-130, 2017
Development of Multifunctional Biopolymeric Auto-Fluorescent Micro-and Nanogels as a Platform for Biomedical Applications
A Vashist, V Atluri, A Raymond, A Kaushik, T Parira, Z Huang, A Durygin, ...
Frontiers in Bioengineering and Biotechnology 8, 315, 2020
Cognate sensor kinase‐independent activation of Mycobacterium tuberculosis response regulator DevR (DosR) by acetyl phosphate: implications in anti …
S Sharma, P Kumari, A Vashist, C Kumar, M Nandi, JS Tyagi
Molecular microbiology 111 (5), 1182-1194, 2019
Preliminary experience with yttrium-90-labelled rituximab (chimeric anti CD-20 antibody) in patients with relapsed and refractory B cell non-Hodgkins lymphoma
P Thakral, S Singla, A Vashist, M P Yadav, S K Gupta, J S Tyagi, ...
Current radiopharmaceuticals 9 (2), 160-168, 2016
Impact of Nanoclay on the pH-Responsiveness and Biodegradable Behavior of Biopolymer-Based Nanocomposite Hydrogels
A Vashist, A Ghosal, A Vashist, A Kaushik, YK Gupta, M Nair, S Ahmad
Gels 5 (4), 44, 2019
Nanogels in the Diagnosis and Treatment of Tuberculosis
V Chopra, G Chauhan, R Kumar, MM Kulkarni, A Vashist
Nanogels for Biomedical Applications, 53-76, 2017
The system can't perform the operation now. Try again later.
Articles 1–20